Francis Green
CSO & Founder
Pharmaceutical Sciences
SolAeroMed Inc.
Canada
Biography
Dr. Green is the co-founder and inventor of the SAMi technology. Dr. Green has more than 30 years of research experience as a respiratory pathologist with international expertise in human and animal models of asthma and inhalation toxicology. Currently Dr. Green serves as professor of Pathology and Laboratory medicine at the University of Calgary and was the previous chair for the Respiratory Research Group at the University of Calgary. As a principal scientist and clinician, Dr. Green has pioneered our understanding of key lung diseases including the pathogenesis of fatal asthma as well as characterization of cystic fibrosis and defects in lung surfactant. Together with Dr. John Butt, Dr. Green first characterized the involvement of obstructive mucous plugs in the pathogenesis of exacerbations for young Asthmatics. Dr. Green is an author of more than 170 peer-reviewed manuscripts and has written numerous book chapters regarding the pathology of occupational lung disease. Dr. Green is the co-founder and inventor of the SAMi technology. Dr. Green has more than 30 years of research experience as a respiratory pathologist with international expertise in human and animal models of asthma and inhalation toxicology. Currently Dr. Green serves as professor of Pathology and Laboratory medicine at the University of Calgary and was the previous chair for the Respiratory Research Group at the University of Calgary. As a principal scientist and clinician, Dr. Green has pioneered our understanding of key lung diseases including the pathogenesis of fatal asthma as well as characterization of cystic fibrosis and defects in lung surfactant. Together with Dr. John Butt, Dr. Green first characterized the involvement of obstructive mucous plugs in the pathogenesis of exacerbations for young Asthmatics. Dr. Green is an author of more than 170 peer-reviewed manuscripts and has written numerous book chapters regarding the pathology of occupational lung disease.
Research Interest
Pharmaceutical Sciences